Evidence map›Paper›PMID 28533638›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.

Kumaraswamy G Kallur, Prashanth G Ramachandra, Krishnappa Rajkumar, Shivakumar S Swamy, Indiresh Desai, Raghavendra M Rao, Shekhar Gowda Patil, P S Sridhar, Nagaraj Madhusudhan, Raghunath S Krishnappa and 4 more

Open access · greenAbstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 5 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 5 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Detection rate of [Frontiers in medicine · 2026
    Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Biological effects ofEuropean radiology · 2026
    Observational
  7. Article
  8. Theranostics in nuclear medicine: the era of precision oncology.Medical oncology (Northwood, London, England) · 2025
    Review
  9. Detection Accuracy of [World journal of nuclear medicine · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. A Prospective Study on [Asia Oceania journal of nuclear medicine & biology · 2021
    Article
  14. Observational
  15. Review
  16. Review
  17. Review
  18. La Radiologia medica · 2018
    Review
  19. Article
  20. Nonspecific Uptake ofIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Kumaraswamy G KallurDept of Molecular Imaging, HCG Foundation, Bengaluru, India.
Prashanth G RamachandraDept of Molecular Imaging, HCG Foundation, Bengaluru, India.
Krishnappa RajkumarDept of Molecular Imaging, HCG Foundation, Bengaluru, India.
Shivakumar S SwamyCenter for Academics and Research, HCG Foundation, Bengaluru, India.
Indiresh DesaiDept of Molecular Imaging, HCG Foundation, Bengaluru, India.
Raghavendra M RaoCenter for Academics and Research, HCG Foundation, Bengaluru, India.
Shekhar Gowda PatilDept of Medical Oncology, HCG Enterprises ltd, Bengaluru, India.
P S SridharDept of Radiation Oncology, HCG Enterprises ltd, Bengaluru, India.
Nagaraj MadhusudhanDept of Radiation Oncology, HCG Enterprises ltd, Bengaluru, India.
Raghunath S KrishnappaDept of Urooncology, HCG Enterprises ltd, Bengaluru, India.
Veerendra BhadrasettyDept of Radiopharmacy, HCG Enterprises ltd, Bengaluru, India.
Hemantha M KumaraDept of Radiopharmacy, HCG Enterprises ltd, Bengaluru, India.
S D SanthoshDept of Radiopharmacy, HCG Enterprises ltd, Bengaluru, India.
Basavalingaiah S AjaikumarDept of Medical Oncology, HCG Enterprises ltd, Bengaluru, India.
Healthcare Global Enterprises · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer is biologically and clinically a heterogeneous disease that makes imaging evaluation challenging. One of the important challenges in this cancer is to detect recurrent disease. Biochemical response using Prostate Specific Antigen (PSA) and Imaging using several PET tracers have poor sensitivity and specificity. Therefore, we analyse the role of Ga68-PSMA (Prostate Specific Membrane Antigen) imaging in prostate cancer, which is a new PET tracer.

methodsIn this study, we evaluated PET scans of 262 patients with diagnosis of prostate cancer. These patients were scanned using Ga68-PSMA for either staging or response evaluation.

results336 PSMA scans were performed. Ga68-PSMA scan resulted in the detection of extra-prostatic disease in 53.2% of cases when done at baseline before commencing any treatment. The sensitivity of Ga68-PSMA at baseline with histopathological diagnosis was 95% with 95% CI ranging from 86% to 98%. The positive predictive value was high at 98% with 95% CI ranging from 91% to 99%. In 26 (10%) patients who had surgical castration, Ga68-PSMA scan was able to detect disease progression / castration resistance in 100% of cases. The outcome of castration-resistant prostate cancer was compared with other cases where castration was not done. In those who did not undergo castration, there was a significantly better response by hormone therapy (p = 0.03) and radiotherapy (p = 0.01) on Ga68-PSMA. The sensitivity of Ga68-PSMA response with biochemical response was 66.7% with 95% CI ranging between 46 %- 82.7%. Ga68-PSMA response did not correlate with biochemical response.

conclusionGa68-PSMA has good sensitivity for diagnosis, staging, restaging, evaluation of therapy response and prognostication in prostate cancer.

Indexed as

diagnosisGa68-PSMAmolecular imagingPET SCANprostate cancer

Identifiers

PMID28533638
PMCPMC5439210
OpenAlexW2595216041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.